Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
2
pubmed:dateCreated
2007-1-9
pubmed:abstractText
After identifying an association between maternal Epstein-Barr virus (EBV) reactivation and acute lymphoblastic leukemia (ALL), the authors analyzed a nested case-control study within Finnish and Icelandic maternity cohorts with 7 million years of follow-up to confirm EBV's role in ALL. Offspring of 550,000 mothers were followed up to age 15 years during 1975-1997 by national cancer registries to identify leukemia cases. Mothers of cases and three quarters of matched mothers of controls were identified by national population registers. First-trimester sera from mothers of 304 ALL cases and 39 non-ALL cases and from 943 mothers of controls were analyzed for antibodies to viral capsid antigen, early antigen, and EBV transactivator protein ZEBRA. Relative risk, estimated as odds ratio (95% confidence interval), was adjusted for birth order and sibship size. Combining early antigen and/or ZEBRA immunoglobulin G antibodies with the presence of viral capsid antigen immunoglobulin M antibodies did not increase the estimate for ALL risk for viral capsid antigen immunoglobulin M alone (odds ratio = 1.9, 95% confidence interval: 1.2, 3.0). Both ZEBRA immunoglobulin G antibodies and viral capsid antigen immunoglobulin M antibodies were associated with an increased risk of non-ALL in the offspring (odds ratio = 4.5, 95% confidence interval: 1.3, 16; odds ratio = 5.6, 95% confidence interval: 1.1, 29, respectively), suggesting EBV reactivation in the mothers of non-ALL cases. EBV reactivation may be associated with a proportion of childhood leukemia.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Jan
pubmed:issn
0002-9262
pubmed:author
pubmed:issnType
Print
pubmed:day
15
pubmed:volume
165
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
134-7
pubmed:dateRevised
2007-11-15
pubmed:meshHeading
pubmed-meshheading:17005627-Adolescent, pubmed-meshheading:17005627-Antibodies, Anti-Idiotypic, pubmed-meshheading:17005627-Antigens, Viral, pubmed-meshheading:17005627-Capsid Proteins, pubmed-meshheading:17005627-Child, pubmed-meshheading:17005627-Child, Preschool, pubmed-meshheading:17005627-Epstein-Barr Virus Infections, pubmed-meshheading:17005627-Female, pubmed-meshheading:17005627-Finland, pubmed-meshheading:17005627-Follow-Up Studies, pubmed-meshheading:17005627-Herpesvirus 4, Human, pubmed-meshheading:17005627-Humans, pubmed-meshheading:17005627-Iceland, pubmed-meshheading:17005627-Immunoglobulin G, pubmed-meshheading:17005627-Incidence, pubmed-meshheading:17005627-Infant, pubmed-meshheading:17005627-Infant, Newborn, pubmed-meshheading:17005627-Maternal Exposure, pubmed-meshheading:17005627-Precursor Cell Lymphoblastic Leukemia-Lymphoma, pubmed-meshheading:17005627-Retrospective Studies, pubmed-meshheading:17005627-Risk Factors, pubmed-meshheading:17005627-Time Factors
pubmed:year
2007
pubmed:articleTitle
Activation of maternal Epstein-Barr virus infection and risk of acute leukemia in the offspring.
pubmed:affiliation
Department of Microbiology, Oncological Center, Aviano, Italy.
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't, Multicenter Study